Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:2
  • preuzimanja u poslednjih 30 dana:1
članak: 1 od 3  
Back povratak na rezultate
Acta Facultatis Medicae Naissensis
2017, vol. 34, br. 1, str. 5-11
jezik rada: engleski
vrsta rada: pregledni članak
doi:10.1515/afmnai-2017-0001
Creative Commons License 4.0
Lečenje bolesnika sa faktorima rizika - komplijansa i adherenca
aUniversity Medical Center Ljubljana, Division of Internal Medicine, Clinical Department for Hypertension, Slovenia + Faculty of Medicine, Department of Internal Medicine, Slovenia
bUniversity of Niš, Faculty of Medicine, Institute for Pathophysiology, Niš

e-adresa: rok.accetto@kclj.si

Sažetak

Hipertenzija i dislipidemije predstavljaju važne faktore rizika za nastanak kardiovaskularnih bolesti koje beleže visoku stopu mortaliteta. Iako znamo kako da lečimo obe vrste oboljenja, stopa uspešnosti lečenja još uvek ostaje niska. Kod više od polovine bolesnika neophodno je prepisati najmanje dva leka protiv povišenog krvnog pritiska kako bi se postigle njegove ciljane vrednosti. Takođe, veoma često se istovremeno javlja i dislipidemija, tako da su bolesnici opterećeni zbog doživotnog uzimanja lekova i adherenca je niska. Predlažemo da se oba stanja leče istovremeno, tačno određenom kombinacijom lekova. Ovakav režim bi povećao adherencu i komplijansu i samim tim omogućio uspešnije lečenje oba stanja.

Ključne reči

Reference

Acceto, R., Dobovišek, J., Dolenc, P., Salobir, B. (2004) Slovenske smernice za obravnavo arterijske hipertenzije 2003. Zdrav Vestn, 73, str. 507-17, (in Slovene)
Accetto, R., Salobir, B. (2009) Epidemiološka raziskava hipertenzije v Sloveniji delno poročilo. u: Dolenc P. [ur.] XVIII. Strokovni sestanek Sekcije za arterijsko hipertenzijo, Zbornik, Portorož, 26. 27. november 2009, Ljubljana: Sekcija za arterijsko hipertenzijo, 9-18
Bangalore, S., Kamalakkannan, G., Parkar, S., Messerli, F.H. (2007) Fixed-dose combinations improve medication compliance: a meta-analysis. American journal of medicine, 120(8): 713-9
Benner, J.S., Glynn, R.J., Mogun, H., Neumann, P.J., Weinstein, M.C., Avorn, J. (2002) Long-term persistence in use of statin therapy in elderly patients. JAMA, 288(4): 455-61
Brookes, L. (2005) ASCOT: Anglo Scandinavian Cardiac Outcomes Trial. Medscape, Oct 04, Available from: http://www.medscape.com/viewarticle/513974
Burnier, M. (2006) Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy. American Journal of Hypertension, 19(11): 1190-1196
Catapano, A.L., Reiner, Ž., de Backer, G., Graham, I., Taskinen, M., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Perrone, F. (2011) ESC/EAS Guidelines for the management of dyslipidaemias. Atherosclerosis, 217(1): 3-46
Chapman, R., Benner, J., Petrilla, A., Tierce, J., Battleman, D., Schwartz, J. (2004) PCV5 PREDICTORS OF ADHERENCE WITH CONCOMITANT ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY. Value in Health, 7(3): 319
Collins, R., MacMahon, S. (1994) Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull, 50(2): 272-98
Dobovišek, J. (1977) Zdravljenje arterijske hipertenzije. Obzornik zdravstvene nege, 11: 21-8
Eurostat Press Office (2012) Europe in figures: Eurostat yearbook: A gateway to European statistics. May 11. Available from: http://europa.eu/rapid/press-release_STAT-12-70_en.htm?locale=en
Fras, Z., Jug, B. (2012) Pregled in poudarki ESC/EAS smernic za obravnavo dislipidemij 2011. u: Slovenski forum za preventivo bolezni srca in žilja 2012, Zbornik, Ljubljana
Fretheim, A., Odgaard-Jensen, J., Brørs, O., Madsen, S., Njølstad, I., Norheim, O.F., Svilaas, A., Kristiansen, I.S., Thürmer, H., Flottorp, S. (2012) Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Medicine, 10(1): 33
Giannattasio, C., Cairo, M., Cesana, F., Alloni, M., Sormani, P., Colombo, G., Grassi, G., Mancia, G. (2012) Blood Pressure Control in Italian Essential Hypertensives Treated by General Practitioners. American Journal of Hypertension, 25(11): 1182-1187
Gupta, A.K., Arshad, S., Poulter, N.R. (2010) Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: A meta-analysis. Hypertension, 55(2): 399-407
Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet, 360(9326): 7-22
Jones, P. H., Nair, R., Thakker, K. M. (2012) Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin-Treated Subjects From 3 Data Sources: A Retrospective Analysis. Journal of the American Heart Association, 1(6): e001800-e001800
Kotsev, K., Woo, D., de Bacque, D., i dr. (2016) EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Card, 23: 636-48
Lewington, S., Clarke, R., Qizilbash, N., i dr. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 360(9349): 1903-1913
Lindsay, P., Bayley, M., Hellings, C., i dr. (2008) Canadian stroke strategy best practices and standards writing group on behalf of the Canadian stroke strategy: A joint initiative of the Canadian Stroke Network and the Heart and Stroke Foundation of Canada. u: Canadian best practice recommendations for stroke care, (updated 2008). CMAJ; 179:E1-E93
Petek-Šter, M., Švab, I. (2007) Nadzor krvnega tlaka pri bolnikih z arterijsko hipertenzijo v Sloveniji. (Blood pressure control in patients with arterial hypertension in Slovenia). Zdrav Vestn, 76: 397-403
Radenković, S. (2013) Rezistentna arterijska hipertenzija - etiopatogenetski, dijagnostički i terapijski karakteri. Niš: Medicinski fakultet, 1. izd. 219
Sherrill, B., Halpern, M., Khan, S., Zhang, J., Panjabi, S. (2011) Single-Pill vs Free-Equivalent Combination Therapies for Hypertension: A Meta-Analysis of Health Care Costs and Adherence. Journal of Clinical Hypertension, 13(12): 898-909
Studies, P., i dr. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet, 370(9602): 1829-1839
World Health Organisation (2013) World health statistics. Available from: http://www.who.int/gho/publications/world_health_statistics/EN_WHS2013_Full.pdf
World Health Organization-WHO Library Cataloguing in-Publication Data (2009) Global health risks: Mortality and burden of disease attributable to selected major risks
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 364(9438): 937-952